Lisa Wiesner
Overview
Explore the profile of Lisa Wiesner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sehner C, Bernier T, Blum K, Clemann N, Glogovac M, Hawkins W, et al.
Regul Toxicol Pharmacol
. 2024 May;
150:105649.
PMID: 38782234
Permitted Daily Exposure Limits (PDEs) are set for Active Pharmaceutical Ingredients (APIs) to control cross-contamination when manufacturing medicinal products in shared facilities. With the lack of official PDE lists for...
2.
Bearth A, Wiesner L, Siegrist M
Food Chem Toxicol
. 2024 Apr;
188:114644.
PMID: 38615796
Next-Generation Risk Assessment (NGRA) aims to implement New Approach Methodologies (NAMs) into risk assessment and to rely on new in vivo testing in animals only as a last resort. However,...
3.
Wiesner L, Araya S, Barle E
J Appl Toxicol
. 2022 Mar;
42(9):1443-1457.
PMID: 35315528
Contract Development and Manufacturing Organizations (CDMOs) that manufacture large, diverse portfolio of chemical and pharmaceutical substances require pragmatic risk-based decisions with respect to the safe carry-over between different chemical entities,...
4.
Kokaliaris C, Garba A, Matuska M, Bronzan R, Colley D, Dorkenoo A, et al.
Lancet Infect Dis
. 2021 Dec;
22(1):136-149.
PMID: 34863336
Background: Over the past 20 years, schistosomiasis control has been scaled up. Preventive chemotherapy with praziquantel is the main intervention. We aimed to assess the effect of preventive chemotherapy on...
5.
Wiesner L, Prause M, Barle E
Pharm Dev Technol
. 2017 May;
23(3):261-264.
PMID: 28535123
Due to newly introduced EU GMP (Good Manufacturing Practice) guideline for Medicinal Products for Human and Veterinary use, product specific permitted daily exposure (PDE) for toxicological evaluation in multi-purpose facilities...
6.
Klin A, Chawarska K, Paul R, Rubin E, Morgan T, Wiesner L, et al.
Am J Psychiatry
. 2004 Oct;
161(11):1981-8.
PMID: 15514396
No abstract available.